Alkermes plc P/FCF
Quel est le P/FCF de Alkermes plc?
Le P/FCF de Alkermes plc est 16.62
Quelle est la définition de P/FCF?
Le rapport prix / flux de trésorerie disponibles (P / FCF) est une mesure d'évaluation qui compare le prix actuel de l'action de la société à son flux de trésorerie disponible par action.
Price to free cash flow (P/FCF) is a measure that value investors find useful to analyze a company’s finances in relation to its current stock price. It is a stricter measure than the price to cash flow ratio as it subtracts capital expenditures from cash flow.
Free cash flow relies heavily on the state of a company's cash from operations, which is in turn heavily influenced by the company's net income. Companies can manipulate their free cash flow by lengthening the time they take to pay their bills, shortening the time it takes to collect what's owed to them, and putting off buying inventory. It also depends on what items are considered capital expenditures and this can be different in case of different companies.
Lower values of P/FCF generally indicate a company that is undervalued and whose stock is relatively cheap in relation to its free cash flow. Conversely, higher P/FCF indicate that the company's stock is relatively overvalued. Value investors thus favor companies with low or decreasing price to free cash flow values that indicate high or increasing free cash flow totals and relatively low stock share prices.
It is best to compare price to free cash flow ratios between similar companies in the same industry. However, the P/FCF metric can also be viewed over a longer time frame to see if the company's cash flow to share price value is improving or declining.
P/FCF des entreprises dans Health Care secteur sur NASDAQ par rapport à Alkermes plc
Que fait Alkermes plc?
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Entreprises avec p/fcf similaire à Alkermes plc
- Splunk Inc a P/FCF de 16.59
- Las Vegas Sands Corp a P/FCF de 16.59
- Copart a P/FCF de 16.60
- Equals plc a P/FCF de 16.60
- Fidelity National Information Services a P/FCF de 16.60
- Laboratorios Farmaceuticos Rovi, S.A a P/FCF de 16.61
- Alkermes plc a P/FCF de 16.62
- WPT Industrial Real Estate Investment Trust a P/FCF de 16.63
- Lucas Bols NV a P/FCF de 16.63
- Innovative-RFK S.p.A a P/FCF de 16.63
- CRH plc a P/FCF de 16.64
- Wyndham Destinations Inc a P/FCF de 16.64
- Enbridge a P/FCF de 16.64